Review



mouse igf2  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Boster Bio mouse igf2
    Mouse Igf2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse igf2/product/Boster Bio
    Average 92 stars, based on 7 article reviews
    mouse igf2 - by Bioz Stars, 2026-02
    92/100 stars

    Images



    Similar Products

    93
    R&D Systems mouse igf ii duoset elisa kit
    Mouse Igf Ii Duoset Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse igf ii duoset elisa kit/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    mouse igf ii duoset elisa kit - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    R&D Systems igf2 elisa kit
    a A phospho-receptor tyrosine kinase (RTK) array with lysates of the indicated CM-treated A549 cells for 30 min. b , f Western blot (WB) analysis of phosphorylated IGF-1R/IR (Y1135/36 for IGF-1R, Y1150/51 for IR) and IR levels in the indicated CM-treated A549 cells for 30 min. αIGF2 Ab : <t>IGF2</t> neutralizing antibody (5 μg/mL) c Immunoprecipitation (IP) analysis of IGF-1R and IR phosphorylation in the indicated CM-treated A549 cells for 30 min. d Real-time PCR analysis of IGF2 , IGF1 , or INS expression in THP-1 cells ( n = 3 biologically independent replicates per group). 2DG: 5 mM 2-deoxy-D-glucose. e WB analysis of IGF2 expression in THP-1 cells. g Real-time PCR analysis of Igf2 mRNA ( n = 3/group), immunohistochemistry (IHC) analysis of pIGF-1R/IR (Y1131 for IGF-1R, Y1146 for IR) expression ( n = 25/group), and IF analysis of IGF2-expressing macrophages (IGF2 + F4/80 + ) ( n = 15/group) in LLC-Luc sc tumors. arb. units.: arbitrary units. h IGF2 <t>ELISA</t> using CM from CD45 - F4/80 - non-immune cells, CD45 + F4/80 - non-macrophage immune cells, and CD45 + F4/80 + macrophages isolated from LLC-Luc sc tumors ( n = 3/group). i, j Anchorage-independent colony formation and sphere formation of the indicated A549 cells treated with the CM from the indicated THP-1 cells ( n = 5 biologically independent replicates per group). k The tumor volume of primary tumors of LLC cells co-injected with the indicated BMDMs ( n = 14/group) and microscopic evaluation H&E-stained lung tissues ( n = 7/group). l The tumor volume of primary tumors ( n = 13 for LLC/sgRNA Con groups and n = 10 for LLC/sgRNA IR groups) and microscopic evaluation H&E-stained lung tissues ( n = 7 for LLC/sgRNA Con groups and n = 6 for LLC/sgRNA IR groups). The data are presented as the mean ± SD. p -values were determined by using one-way ANOVA with Tukey’s post-hoc test ( d , i , j ), a two-tailed Student’s t -test ( g , h ), or Kruskal–Wallis test with Dunn’s post-hoc test ( k , l ). The data shown in b – f , i , j are representative of two independent experiments with similar results. Source data are provided as a Source Data file.
    Igf2 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/igf2 elisa kit/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    igf2 elisa kit - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    94
    R&D Systems r d systems mouse rat porcine canine igf
    a A phospho-receptor tyrosine kinase (RTK) array with lysates of the indicated CM-treated A549 cells for 30 min. b , f Western blot (WB) analysis of phosphorylated IGF-1R/IR (Y1135/36 for IGF-1R, Y1150/51 for IR) and IR levels in the indicated CM-treated A549 cells for 30 min. αIGF2 Ab : <t>IGF2</t> neutralizing antibody (5 μg/mL) c Immunoprecipitation (IP) analysis of IGF-1R and IR phosphorylation in the indicated CM-treated A549 cells for 30 min. d Real-time PCR analysis of IGF2 , IGF1 , or INS expression in THP-1 cells ( n = 3 biologically independent replicates per group). 2DG: 5 mM 2-deoxy-D-glucose. e WB analysis of IGF2 expression in THP-1 cells. g Real-time PCR analysis of Igf2 mRNA ( n = 3/group), immunohistochemistry (IHC) analysis of pIGF-1R/IR (Y1131 for IGF-1R, Y1146 for IR) expression ( n = 25/group), and IF analysis of IGF2-expressing macrophages (IGF2 + F4/80 + ) ( n = 15/group) in LLC-Luc sc tumors. arb. units.: arbitrary units. h IGF2 <t>ELISA</t> using CM from CD45 - F4/80 - non-immune cells, CD45 + F4/80 - non-macrophage immune cells, and CD45 + F4/80 + macrophages isolated from LLC-Luc sc tumors ( n = 3/group). i, j Anchorage-independent colony formation and sphere formation of the indicated A549 cells treated with the CM from the indicated THP-1 cells ( n = 5 biologically independent replicates per group). k The tumor volume of primary tumors of LLC cells co-injected with the indicated BMDMs ( n = 14/group) and microscopic evaluation H&E-stained lung tissues ( n = 7/group). l The tumor volume of primary tumors ( n = 13 for LLC/sgRNA Con groups and n = 10 for LLC/sgRNA IR groups) and microscopic evaluation H&E-stained lung tissues ( n = 7 for LLC/sgRNA Con groups and n = 6 for LLC/sgRNA IR groups). The data are presented as the mean ± SD. p -values were determined by using one-way ANOVA with Tukey’s post-hoc test ( d , i , j ), a two-tailed Student’s t -test ( g , h ), or Kruskal–Wallis test with Dunn’s post-hoc test ( k , l ). The data shown in b – f , i , j are representative of two independent experiments with similar results. Source data are provided as a Source Data file.
    R D Systems Mouse Rat Porcine Canine Igf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/r d systems mouse rat porcine canine igf/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    r d systems mouse rat porcine canine igf - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    92
    Boster Bio mouse igf2
    a A phospho-receptor tyrosine kinase (RTK) array with lysates of the indicated CM-treated A549 cells for 30 min. b , f Western blot (WB) analysis of phosphorylated IGF-1R/IR (Y1135/36 for IGF-1R, Y1150/51 for IR) and IR levels in the indicated CM-treated A549 cells for 30 min. αIGF2 Ab : <t>IGF2</t> neutralizing antibody (5 μg/mL) c Immunoprecipitation (IP) analysis of IGF-1R and IR phosphorylation in the indicated CM-treated A549 cells for 30 min. d Real-time PCR analysis of IGF2 , IGF1 , or INS expression in THP-1 cells ( n = 3 biologically independent replicates per group). 2DG: 5 mM 2-deoxy-D-glucose. e WB analysis of IGF2 expression in THP-1 cells. g Real-time PCR analysis of Igf2 mRNA ( n = 3/group), immunohistochemistry (IHC) analysis of pIGF-1R/IR (Y1131 for IGF-1R, Y1146 for IR) expression ( n = 25/group), and IF analysis of IGF2-expressing macrophages (IGF2 + F4/80 + ) ( n = 15/group) in LLC-Luc sc tumors. arb. units.: arbitrary units. h IGF2 <t>ELISA</t> using CM from CD45 - F4/80 - non-immune cells, CD45 + F4/80 - non-macrophage immune cells, and CD45 + F4/80 + macrophages isolated from LLC-Luc sc tumors ( n = 3/group). i, j Anchorage-independent colony formation and sphere formation of the indicated A549 cells treated with the CM from the indicated THP-1 cells ( n = 5 biologically independent replicates per group). k The tumor volume of primary tumors of LLC cells co-injected with the indicated BMDMs ( n = 14/group) and microscopic evaluation H&E-stained lung tissues ( n = 7/group). l The tumor volume of primary tumors ( n = 13 for LLC/sgRNA Con groups and n = 10 for LLC/sgRNA IR groups) and microscopic evaluation H&E-stained lung tissues ( n = 7 for LLC/sgRNA Con groups and n = 6 for LLC/sgRNA IR groups). The data are presented as the mean ± SD. p -values were determined by using one-way ANOVA with Tukey’s post-hoc test ( d , i , j ), a two-tailed Student’s t -test ( g , h ), or Kruskal–Wallis test with Dunn’s post-hoc test ( k , l ). The data shown in b – f , i , j are representative of two independent experiments with similar results. Source data are provided as a Source Data file.
    Mouse Igf2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse igf2/product/Boster Bio
    Average 92 stars, based on 1 article reviews
    mouse igf2 - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    94
    R&D Systems igf2
    Figure 5. Circulating levels of free insulin-like growth factor (IGF) 1 (A), total IGF1 (B), <t>IGF2</t> (C), IGF binding protein (IGFBP) 2 (D) and leptin (E) in mice fed chow or a high-fat diet (HFD) for 4 months (HHHH), chow diet for 3 months and an additional month on a HFD (CCCH), or HFD for 2 months followed by chow for 1 month and then HFD for the last month (HHCH). ***p < 0.001. a: effect of the sex, b: effect of the diet. NS non-significant. n = 9.
    Igf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/igf2/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    igf2 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    R&D Systems mouse rat porcine canine igf
    Figure 5. Circulating levels of free insulin-like growth factor (IGF) 1 (A), total IGF1 (B), <t>IGF2</t> (C), IGF binding protein (IGFBP) 2 (D) and leptin (E) in mice fed chow or a high-fat diet (HFD) for 4 months (HHHH), chow diet for 3 months and an additional month on a HFD (CCCH), or HFD for 2 months followed by chow for 1 month and then HFD for the last month (HHCH). ***p < 0.001. a: effect of the sex, b: effect of the diet. NS non-significant. n = 9.
    Mouse Rat Porcine Canine Igf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse rat porcine canine igf/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mouse rat porcine canine igf - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    R&D Systems mouse igf2 quantikinetm elisa kit
    Figure 5. Circulating levels of free insulin-like growth factor (IGF) 1 (A), total IGF1 (B), <t>IGF2</t> (C), IGF binding protein (IGFBP) 2 (D) and leptin (E) in mice fed chow or a high-fat diet (HFD) for 4 months (HHHH), chow diet for 3 months and an additional month on a HFD (CCCH), or HFD for 2 months followed by chow for 1 month and then HFD for the last month (HHCH). ***p < 0.001. a: effect of the sex, b: effect of the diet. NS non-significant. n = 9.
    Mouse Igf2 Quantikinetm Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse igf2 quantikinetm elisa kit/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mouse igf2 quantikinetm elisa kit - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    a A phospho-receptor tyrosine kinase (RTK) array with lysates of the indicated CM-treated A549 cells for 30 min. b , f Western blot (WB) analysis of phosphorylated IGF-1R/IR (Y1135/36 for IGF-1R, Y1150/51 for IR) and IR levels in the indicated CM-treated A549 cells for 30 min. αIGF2 Ab : IGF2 neutralizing antibody (5 μg/mL) c Immunoprecipitation (IP) analysis of IGF-1R and IR phosphorylation in the indicated CM-treated A549 cells for 30 min. d Real-time PCR analysis of IGF2 , IGF1 , or INS expression in THP-1 cells ( n = 3 biologically independent replicates per group). 2DG: 5 mM 2-deoxy-D-glucose. e WB analysis of IGF2 expression in THP-1 cells. g Real-time PCR analysis of Igf2 mRNA ( n = 3/group), immunohistochemistry (IHC) analysis of pIGF-1R/IR (Y1131 for IGF-1R, Y1146 for IR) expression ( n = 25/group), and IF analysis of IGF2-expressing macrophages (IGF2 + F4/80 + ) ( n = 15/group) in LLC-Luc sc tumors. arb. units.: arbitrary units. h IGF2 ELISA using CM from CD45 - F4/80 - non-immune cells, CD45 + F4/80 - non-macrophage immune cells, and CD45 + F4/80 + macrophages isolated from LLC-Luc sc tumors ( n = 3/group). i, j Anchorage-independent colony formation and sphere formation of the indicated A549 cells treated with the CM from the indicated THP-1 cells ( n = 5 biologically independent replicates per group). k The tumor volume of primary tumors of LLC cells co-injected with the indicated BMDMs ( n = 14/group) and microscopic evaluation H&E-stained lung tissues ( n = 7/group). l The tumor volume of primary tumors ( n = 13 for LLC/sgRNA Con groups and n = 10 for LLC/sgRNA IR groups) and microscopic evaluation H&E-stained lung tissues ( n = 7 for LLC/sgRNA Con groups and n = 6 for LLC/sgRNA IR groups). The data are presented as the mean ± SD. p -values were determined by using one-way ANOVA with Tukey’s post-hoc test ( d , i , j ), a two-tailed Student’s t -test ( g , h ), or Kruskal–Wallis test with Dunn’s post-hoc test ( k , l ). The data shown in b – f , i , j are representative of two independent experiments with similar results. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Tobacco-induced hyperglycemia promotes lung cancer progression via cancer cell-macrophage interaction through paracrine IGF2/IR/NPM1-driven PD-L1 expression

    doi: 10.1038/s41467-024-49199-9

    Figure Lengend Snippet: a A phospho-receptor tyrosine kinase (RTK) array with lysates of the indicated CM-treated A549 cells for 30 min. b , f Western blot (WB) analysis of phosphorylated IGF-1R/IR (Y1135/36 for IGF-1R, Y1150/51 for IR) and IR levels in the indicated CM-treated A549 cells for 30 min. αIGF2 Ab : IGF2 neutralizing antibody (5 μg/mL) c Immunoprecipitation (IP) analysis of IGF-1R and IR phosphorylation in the indicated CM-treated A549 cells for 30 min. d Real-time PCR analysis of IGF2 , IGF1 , or INS expression in THP-1 cells ( n = 3 biologically independent replicates per group). 2DG: 5 mM 2-deoxy-D-glucose. e WB analysis of IGF2 expression in THP-1 cells. g Real-time PCR analysis of Igf2 mRNA ( n = 3/group), immunohistochemistry (IHC) analysis of pIGF-1R/IR (Y1131 for IGF-1R, Y1146 for IR) expression ( n = 25/group), and IF analysis of IGF2-expressing macrophages (IGF2 + F4/80 + ) ( n = 15/group) in LLC-Luc sc tumors. arb. units.: arbitrary units. h IGF2 ELISA using CM from CD45 - F4/80 - non-immune cells, CD45 + F4/80 - non-macrophage immune cells, and CD45 + F4/80 + macrophages isolated from LLC-Luc sc tumors ( n = 3/group). i, j Anchorage-independent colony formation and sphere formation of the indicated A549 cells treated with the CM from the indicated THP-1 cells ( n = 5 biologically independent replicates per group). k The tumor volume of primary tumors of LLC cells co-injected with the indicated BMDMs ( n = 14/group) and microscopic evaluation H&E-stained lung tissues ( n = 7/group). l The tumor volume of primary tumors ( n = 13 for LLC/sgRNA Con groups and n = 10 for LLC/sgRNA IR groups) and microscopic evaluation H&E-stained lung tissues ( n = 7 for LLC/sgRNA Con groups and n = 6 for LLC/sgRNA IR groups). The data are presented as the mean ± SD. p -values were determined by using one-way ANOVA with Tukey’s post-hoc test ( d , i , j ), a two-tailed Student’s t -test ( g , h ), or Kruskal–Wallis test with Dunn’s post-hoc test ( k , l ). The data shown in b – f , i , j are representative of two independent experiments with similar results. Source data are provided as a Source Data file.

    Article Snippet: The level of IGF2 in CM was determined by an IGF2 ELISA kit (cat. no. MG200, R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions and normalized by the protein concentration of attached cells remaining after CM collection.

    Techniques: Western Blot, Immunoprecipitation, Real-time Polymerase Chain Reaction, Expressing, Immunohistochemistry, Enzyme-linked Immunosorbent Assay, Isolation, Injection, Staining, Two Tailed Test

    a Western blot (WB) analysis using the nuclear extract (NE) of CM-treated A549 cells. b Quantification of the immunofluorescence staining of nuclear phosphorylated IGF-1R/IR (pIGF-1R/IR, [Y1131 for IGF-1R, Y1146 for IR]) ( n = 5 biologically independent replicates/group). arb. units.: arbitrary units. c Streptavidin pulldown analysis on membrane fractions (MEM), cytosol extracts (CE), and NE of IGF2 (50 ng/mL)-stimulated A549 cells. d WB analysis of non-chromatin (Chr-unbound) and chromatin (Chr-bound) fractions. e Immunoprecipitation (IP) analysis of the association of IR with KPNB1 and KPNA2 in IGF2-stimulated A549 cells. f WB analysis of nuclear pIGF-1R/IR (Y1135/36 for IGF-1R, Y1150/51 for IR) and IR levels in A549 cells. WCL: whole-cell lysates. g A representative image of Coomassie blue-stained gel on resolved anti-IR immunoprecipitants and common nuclear IR-associated proteins identified by LC-MS/MS analysis. NCL: nucleolin. h IP of the association of IR with NPM1, histones, and RNA polymerase II (Pol II) in A549 cells. i Schematic diagram depicting full-length (FL) and truncation mutants of NPM1. OD: oligomerization domain. HBD: histone binding domain. NBD: nucleic acid-binding domain. j Representative WB images of IP analysis and quantitative analysis ( n = 3 biologically independent replicates/group) for the association of IR with NPM1 (FL or truncation mutants) in IGF2-stimulated H226Br cells for 3 h. k The association of IR with FL or HBD deletion mutant (ΔHBD) of NPM1 in IGF2-stimulated H226Br cells for 3 h. l Anchorage-independent colony formation ( n = 3 biologically independent replicates/group) and sphere formation ( n = 4 biologically independent replicates/group) capacities of the indicated A549 cells. m Schematic diagrams of experiments and quantitative analyzes of primary and metastatic lung tumor growth (LLC/sgRNA Con + BMDM-Veh: n = 8; LLC/sgRNA Con + BMDM-NB and LLC/sgRNA NPM1 + BMDM-Veh: n = 6; LLC/sgRNA NPM1 + BMDM-NB: n = 5). The data are presented as the mean ± SD. p -values were determined by using one-way ANOVA with Tukey’s post-hoc test ( b , j , l ) or Kruskal-Wallis test with Dunn’s post-hoc test ( m ). The data are representative of two (data shown in a – f , h , k , l ) or three (data shown in j ) independent experiments with similar results. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Tobacco-induced hyperglycemia promotes lung cancer progression via cancer cell-macrophage interaction through paracrine IGF2/IR/NPM1-driven PD-L1 expression

    doi: 10.1038/s41467-024-49199-9

    Figure Lengend Snippet: a Western blot (WB) analysis using the nuclear extract (NE) of CM-treated A549 cells. b Quantification of the immunofluorescence staining of nuclear phosphorylated IGF-1R/IR (pIGF-1R/IR, [Y1131 for IGF-1R, Y1146 for IR]) ( n = 5 biologically independent replicates/group). arb. units.: arbitrary units. c Streptavidin pulldown analysis on membrane fractions (MEM), cytosol extracts (CE), and NE of IGF2 (50 ng/mL)-stimulated A549 cells. d WB analysis of non-chromatin (Chr-unbound) and chromatin (Chr-bound) fractions. e Immunoprecipitation (IP) analysis of the association of IR with KPNB1 and KPNA2 in IGF2-stimulated A549 cells. f WB analysis of nuclear pIGF-1R/IR (Y1135/36 for IGF-1R, Y1150/51 for IR) and IR levels in A549 cells. WCL: whole-cell lysates. g A representative image of Coomassie blue-stained gel on resolved anti-IR immunoprecipitants and common nuclear IR-associated proteins identified by LC-MS/MS analysis. NCL: nucleolin. h IP of the association of IR with NPM1, histones, and RNA polymerase II (Pol II) in A549 cells. i Schematic diagram depicting full-length (FL) and truncation mutants of NPM1. OD: oligomerization domain. HBD: histone binding domain. NBD: nucleic acid-binding domain. j Representative WB images of IP analysis and quantitative analysis ( n = 3 biologically independent replicates/group) for the association of IR with NPM1 (FL or truncation mutants) in IGF2-stimulated H226Br cells for 3 h. k The association of IR with FL or HBD deletion mutant (ΔHBD) of NPM1 in IGF2-stimulated H226Br cells for 3 h. l Anchorage-independent colony formation ( n = 3 biologically independent replicates/group) and sphere formation ( n = 4 biologically independent replicates/group) capacities of the indicated A549 cells. m Schematic diagrams of experiments and quantitative analyzes of primary and metastatic lung tumor growth (LLC/sgRNA Con + BMDM-Veh: n = 8; LLC/sgRNA Con + BMDM-NB and LLC/sgRNA NPM1 + BMDM-Veh: n = 6; LLC/sgRNA NPM1 + BMDM-NB: n = 5). The data are presented as the mean ± SD. p -values were determined by using one-way ANOVA with Tukey’s post-hoc test ( b , j , l ) or Kruskal-Wallis test with Dunn’s post-hoc test ( m ). The data are representative of two (data shown in a – f , h , k , l ) or three (data shown in j ) independent experiments with similar results. Source data are provided as a Source Data file.

    Article Snippet: The level of IGF2 in CM was determined by an IGF2 ELISA kit (cat. no. MG200, R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions and normalized by the protein concentration of attached cells remaining after CM collection.

    Techniques: Western Blot, Immunofluorescence, Staining, Membrane, Immunoprecipitation, Liquid Chromatography with Mass Spectroscopy, Binding Assay, Mutagenesis

    a – d Western blot (WB) analysis of the indicated protein expression in A549 and H226Br cells and their subclones. Cells were stimulated with IGF2 (50 ng/mL) for one day ( a , b ) or incubated with CM THP-Veh or CM THP-NB for one day ( c , d ). e – g Indicated LC cells were exposed to IGF2 (50 ng/mL) for 3 h (for chromatin immunoprecipitation [ChIP] assay) ( e , f ) or 24 h (for luciferase reporter assay) ( g ). e , f ChIP assay of IR ( e , f ) or NPM1 ( e ) binding to the P3 region of the CD274 promoter ( n = 3 biologically independent replicates/group). g Luciferase reporter assay of activation of the CD274 promoter ( n = 3 biologically independent replicates/group). h WB analysis of the effect of IGF2 stimulation (50 ng/mL for 24 h) on the indicated protein expression in H226Br cells. i – m B6 mice carrying LLC-Luc ortho were exposed to Veh or NB under HCD condition, either alone or together with intraperitoneal injection of anti-PD-L1 antibody (αPD-L1 Ab , 100 μg in 100 μL/mouse, twice a week). The data is representative of two independent experiments. i Schematic diagram of the experimental schedule. j Representative ex vivo bioluminescence images of analyzed organs k Quantitative analyzes of bioluminescence intensity (BLI) of analyzed organs ( n = 12/group for the Veh/HCD group; n = 11/group for the NB/HCD group; n = 13/group for the NB/HCD/αPD-L1 Ab group). l Microscopic evaluation of H&E-stained lung and liver tissues for tumor multiplicity and burden ( n = 10/group for the Veh/HCD group; n = 9/group for the NB/HCD group; n = 11/group for the NB/HCD/αPD-L1 Ab group). m Kaplan–Meier survival curve of the mice in each group ( n = 12/group). The data are presented as the mean ± SD. p -values were determined by using one-way ANOVA with Tukey’s post-hoc test ( e – g ), Kruskal–Wallis test with Dunn’s post-hoc test ( k , l ), or a log-rank test ( m ). The data shown in a – h are representative of two independent experiments with similar results. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Tobacco-induced hyperglycemia promotes lung cancer progression via cancer cell-macrophage interaction through paracrine IGF2/IR/NPM1-driven PD-L1 expression

    doi: 10.1038/s41467-024-49199-9

    Figure Lengend Snippet: a – d Western blot (WB) analysis of the indicated protein expression in A549 and H226Br cells and their subclones. Cells were stimulated with IGF2 (50 ng/mL) for one day ( a , b ) or incubated with CM THP-Veh or CM THP-NB for one day ( c , d ). e – g Indicated LC cells were exposed to IGF2 (50 ng/mL) for 3 h (for chromatin immunoprecipitation [ChIP] assay) ( e , f ) or 24 h (for luciferase reporter assay) ( g ). e , f ChIP assay of IR ( e , f ) or NPM1 ( e ) binding to the P3 region of the CD274 promoter ( n = 3 biologically independent replicates/group). g Luciferase reporter assay of activation of the CD274 promoter ( n = 3 biologically independent replicates/group). h WB analysis of the effect of IGF2 stimulation (50 ng/mL for 24 h) on the indicated protein expression in H226Br cells. i – m B6 mice carrying LLC-Luc ortho were exposed to Veh or NB under HCD condition, either alone or together with intraperitoneal injection of anti-PD-L1 antibody (αPD-L1 Ab , 100 μg in 100 μL/mouse, twice a week). The data is representative of two independent experiments. i Schematic diagram of the experimental schedule. j Representative ex vivo bioluminescence images of analyzed organs k Quantitative analyzes of bioluminescence intensity (BLI) of analyzed organs ( n = 12/group for the Veh/HCD group; n = 11/group for the NB/HCD group; n = 13/group for the NB/HCD/αPD-L1 Ab group). l Microscopic evaluation of H&E-stained lung and liver tissues for tumor multiplicity and burden ( n = 10/group for the Veh/HCD group; n = 9/group for the NB/HCD group; n = 11/group for the NB/HCD/αPD-L1 Ab group). m Kaplan–Meier survival curve of the mice in each group ( n = 12/group). The data are presented as the mean ± SD. p -values were determined by using one-way ANOVA with Tukey’s post-hoc test ( e – g ), Kruskal–Wallis test with Dunn’s post-hoc test ( k , l ), or a log-rank test ( m ). The data shown in a – h are representative of two independent experiments with similar results. Source data are provided as a Source Data file.

    Article Snippet: The level of IGF2 in CM was determined by an IGF2 ELISA kit (cat. no. MG200, R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions and normalized by the protein concentration of attached cells remaining after CM collection.

    Techniques: Western Blot, Expressing, Incubation, Chromatin Immunoprecipitation, Luciferase, Reporter Assay, Binding Assay, Activation Assay, Injection, Ex Vivo, Staining

    a Representative immunofluorescence (IF) images and quantitative analyzes of the indicated markers in patient-derived lung tissues from non-smokers ( n = 3/group, 5 fields/slide [ n = 15/group]) and smokers ( n = 5/group, 6 fields/slide [ n = 30/group]). Scale bar: 100 μm. b Representative IF staining images of the indicated markers using a tissue microarray (TMA) ( n = 21 for the TNM N0 group; n = 14 for the TNM N1/2 group). Scale bars: 20 μm. c , left Correlation analysis for the Pearson correlation coefficient between IGF2 and GLUT1 levels in macrophages ( n = 35/group). c , right Correlation analysis for the Spearman rank correlation coefficient between nuclear pIGF-1R/IR (Y1131 for IGF-1R, Y1146 for IR) and PD-L1 in tumor cells ( n = 35/group). d Pie charts showing the levels of indicated markers in tumor tissues from patients with or without lymph node metastasis (N0 or N1/2, respectively; n = 21 for the TNM N0 group; n = 14 for the TNM N1/2 group). e Association of the expression level of the indicated markers with cancer stage (left, n = 16 for the stage I group; n = 14 for the stage II group; n = 5 for the stage III group) and tumor grade (right, n = 5 for the grade 1–2 group; n = 20 for the grade 2-3 group; n = 8 for the grade 3 group). f Analysis of a publicly available dataset (GSE30219) to determine the association of GLUT1 or GLUT3 levels with overall and disease-free survival (OS [ n = 136/group] and DFS [ n = 129/group], respectively) in patients with NSCLC. The data are presented as the mean ± SD. p -values were determined by using a two-tailed Student’s t -test ( a , b ), two-tailed Mann-Whitney test ( a ), one-way ANOVA with Tukey’s post-hoc test ( e ), Kruskal–Wallis test with Dunn’s post-hoc test ( e ), or a log-rank test ( f ). Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Tobacco-induced hyperglycemia promotes lung cancer progression via cancer cell-macrophage interaction through paracrine IGF2/IR/NPM1-driven PD-L1 expression

    doi: 10.1038/s41467-024-49199-9

    Figure Lengend Snippet: a Representative immunofluorescence (IF) images and quantitative analyzes of the indicated markers in patient-derived lung tissues from non-smokers ( n = 3/group, 5 fields/slide [ n = 15/group]) and smokers ( n = 5/group, 6 fields/slide [ n = 30/group]). Scale bar: 100 μm. b Representative IF staining images of the indicated markers using a tissue microarray (TMA) ( n = 21 for the TNM N0 group; n = 14 for the TNM N1/2 group). Scale bars: 20 μm. c , left Correlation analysis for the Pearson correlation coefficient between IGF2 and GLUT1 levels in macrophages ( n = 35/group). c , right Correlation analysis for the Spearman rank correlation coefficient between nuclear pIGF-1R/IR (Y1131 for IGF-1R, Y1146 for IR) and PD-L1 in tumor cells ( n = 35/group). d Pie charts showing the levels of indicated markers in tumor tissues from patients with or without lymph node metastasis (N0 or N1/2, respectively; n = 21 for the TNM N0 group; n = 14 for the TNM N1/2 group). e Association of the expression level of the indicated markers with cancer stage (left, n = 16 for the stage I group; n = 14 for the stage II group; n = 5 for the stage III group) and tumor grade (right, n = 5 for the grade 1–2 group; n = 20 for the grade 2-3 group; n = 8 for the grade 3 group). f Analysis of a publicly available dataset (GSE30219) to determine the association of GLUT1 or GLUT3 levels with overall and disease-free survival (OS [ n = 136/group] and DFS [ n = 129/group], respectively) in patients with NSCLC. The data are presented as the mean ± SD. p -values were determined by using a two-tailed Student’s t -test ( a , b ), two-tailed Mann-Whitney test ( a ), one-way ANOVA with Tukey’s post-hoc test ( e ), Kruskal–Wallis test with Dunn’s post-hoc test ( e ), or a log-rank test ( f ). Source data are provided as a Source Data file.

    Article Snippet: The level of IGF2 in CM was determined by an IGF2 ELISA kit (cat. no. MG200, R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions and normalized by the protein concentration of attached cells remaining after CM collection.

    Techniques: Immunofluorescence, Derivative Assay, Staining, Microarray, Expressing, Two Tailed Test, MANN-WHITNEY

    In a glucose-rich microenvironment caused by systemic NB-induced hyperglycemia, NB increases glucose utilization in macrophages through GLUT1 and GLUT3 transcription and membranous localization upregulation, thereby inducing IGF2 transcription in macrophages. IGF2 stimulates IR in tumor cells in a paracrine manner, resulting in PD-L1 expression upregulation through IR nuclear translocation and a complex formation with NPM1 and Pol II. These events lead to the acquisition of cancer stem cell-like and immune-evasive properties in tumor cells, ultimately mediating metastatic tumor formation.

    Journal: Nature Communications

    Article Title: Tobacco-induced hyperglycemia promotes lung cancer progression via cancer cell-macrophage interaction through paracrine IGF2/IR/NPM1-driven PD-L1 expression

    doi: 10.1038/s41467-024-49199-9

    Figure Lengend Snippet: In a glucose-rich microenvironment caused by systemic NB-induced hyperglycemia, NB increases glucose utilization in macrophages through GLUT1 and GLUT3 transcription and membranous localization upregulation, thereby inducing IGF2 transcription in macrophages. IGF2 stimulates IR in tumor cells in a paracrine manner, resulting in PD-L1 expression upregulation through IR nuclear translocation and a complex formation with NPM1 and Pol II. These events lead to the acquisition of cancer stem cell-like and immune-evasive properties in tumor cells, ultimately mediating metastatic tumor formation.

    Article Snippet: The level of IGF2 in CM was determined by an IGF2 ELISA kit (cat. no. MG200, R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions and normalized by the protein concentration of attached cells remaining after CM collection.

    Techniques: Expressing, Translocation Assay

    Figure 5. Circulating levels of free insulin-like growth factor (IGF) 1 (A), total IGF1 (B), IGF2 (C), IGF binding protein (IGFBP) 2 (D) and leptin (E) in mice fed chow or a high-fat diet (HFD) for 4 months (HHHH), chow diet for 3 months and an additional month on a HFD (CCCH), or HFD for 2 months followed by chow for 1 month and then HFD for the last month (HHCH). ***p < 0.001. a: effect of the sex, b: effect of the diet. NS non-significant. n = 9.

    Journal: Scientific reports

    Article Title: The metabolic effects of resumption of a high fat diet after weight loss are sex dependent in mice.

    doi: 10.1038/s41598-023-40514-w

    Figure Lengend Snippet: Figure 5. Circulating levels of free insulin-like growth factor (IGF) 1 (A), total IGF1 (B), IGF2 (C), IGF binding protein (IGFBP) 2 (D) and leptin (E) in mice fed chow or a high-fat diet (HFD) for 4 months (HHHH), chow diet for 3 months and an additional month on a HFD (CCCH), or HFD for 2 months followed by chow for 1 month and then HFD for the last month (HHCH). ***p < 0.001. a: effect of the sex, b: effect of the diet. NS non-significant. n = 9.

    Article Snippet: Plasma levels of free IGF1 (Ref.: AL-136, AnshLabs, Webster, TX, USA), total IGF1 (Ref.: E25; Mediagnost, Reutlingen, Germany), IGF2 (Ref.: MG200; R&D Systems, Minneapolis, Minnesota, USA), IGFBP2 (Ref.: RAB0234; Millipore, Burlington, MA, USA), insulin (Ref.: EZRMI-13K; Millipore) and leptin (Ref.: EZML-82K; Millipore) were assayed according to manufacturer’s instructions, and absorbance was read using a TECAN Infinite M200.

    Techniques: Binding Assay

    Figure 6. Relative mRNA levels of insulin-like growth factor (IGF) 1 (A), IGF2 (B), IGF binding protein (IGFBP)2 (C), neuropeptide Y (NPY; E), Agouti-related protein (AgRP; F), and proopiomelanocortin (POMC; G) in the hypothalamus, as well as the correlation of hypothalamic IGF2 and IGFBP2 mRNA levels (D), in mice fed chow or a high-fat diet (HFD) for 4 months (HHHH), a chow diet for 3 months and an additional month on a HFD (CCCH), or HFD for 2 months followed by chow for 1 month and then HFD for the last month (HHCH). *p < 0.05, ***p < 0.001. a: effect of the sex, b: effect of the diet. n = 6.

    Journal: Scientific reports

    Article Title: The metabolic effects of resumption of a high fat diet after weight loss are sex dependent in mice.

    doi: 10.1038/s41598-023-40514-w

    Figure Lengend Snippet: Figure 6. Relative mRNA levels of insulin-like growth factor (IGF) 1 (A), IGF2 (B), IGF binding protein (IGFBP)2 (C), neuropeptide Y (NPY; E), Agouti-related protein (AgRP; F), and proopiomelanocortin (POMC; G) in the hypothalamus, as well as the correlation of hypothalamic IGF2 and IGFBP2 mRNA levels (D), in mice fed chow or a high-fat diet (HFD) for 4 months (HHHH), a chow diet for 3 months and an additional month on a HFD (CCCH), or HFD for 2 months followed by chow for 1 month and then HFD for the last month (HHCH). *p < 0.05, ***p < 0.001. a: effect of the sex, b: effect of the diet. n = 6.

    Article Snippet: Plasma levels of free IGF1 (Ref.: AL-136, AnshLabs, Webster, TX, USA), total IGF1 (Ref.: E25; Mediagnost, Reutlingen, Germany), IGF2 (Ref.: MG200; R&D Systems, Minneapolis, Minnesota, USA), IGFBP2 (Ref.: RAB0234; Millipore, Burlington, MA, USA), insulin (Ref.: EZRMI-13K; Millipore) and leptin (Ref.: EZML-82K; Millipore) were assayed according to manufacturer’s instructions, and absorbance was read using a TECAN Infinite M200.

    Techniques: Binding Assay

    Figure 7. Cell number (A) and the relative IGF1 (B), IGF2 receptor (IGF2R, C) and IGFBP2 (D) mRNA levels in hypothalamic astrocyte cultures from male and female rats after 24 h of IGF2 treatment at 10, 25, 100 or 200 ng/ml. **p < 0.01. a: effect of the sex; #, general effect of IGF2; δ, effect of the dose of IGF2. n = 3.

    Journal: Scientific reports

    Article Title: The metabolic effects of resumption of a high fat diet after weight loss are sex dependent in mice.

    doi: 10.1038/s41598-023-40514-w

    Figure Lengend Snippet: Figure 7. Cell number (A) and the relative IGF1 (B), IGF2 receptor (IGF2R, C) and IGFBP2 (D) mRNA levels in hypothalamic astrocyte cultures from male and female rats after 24 h of IGF2 treatment at 10, 25, 100 or 200 ng/ml. **p < 0.01. a: effect of the sex; #, general effect of IGF2; δ, effect of the dose of IGF2. n = 3.

    Article Snippet: Plasma levels of free IGF1 (Ref.: AL-136, AnshLabs, Webster, TX, USA), total IGF1 (Ref.: E25; Mediagnost, Reutlingen, Germany), IGF2 (Ref.: MG200; R&D Systems, Minneapolis, Minnesota, USA), IGFBP2 (Ref.: RAB0234; Millipore, Burlington, MA, USA), insulin (Ref.: EZRMI-13K; Millipore) and leptin (Ref.: EZML-82K; Millipore) were assayed according to manufacturer’s instructions, and absorbance was read using a TECAN Infinite M200.

    Techniques: